中药银屑1号方治疗寻常型银屑病临床观察

目的:观察中药复方银屑1号方治疗寻常型银屑病的临床疗效。方法:纳入102例寻常型银屑病患者,随机分为中药复方银屑1号方组(A组)、雷公藤多苷片组(B组)、中药复方银屑1号方合雷公藤多苷片组(C组),治疗1个月后进行临床疗效评价。结果:A组治愈率、总显效率分别为28.1%、65.6%,B组治愈率、总显效率为22.9%和65.7%,而C组治愈率、总显效率分别为45.7%和85.7%。经卡方检验,A、B组间比较,P>0.05,没有统计学意义;C组和A、B组比较,P<0.05,有显著的统计学意义,提示银屑1号方合雷公藤多苷片治疗寻常型银屑病疗效明显优于单独用药。结论:银屑1号方合用雷公藤多苷片治疗寻常型银屑病的疗效较好,值得临床推广。

Clinical Observation of Psoriasis Vulgaris Treated by No.1 Yinxie Formula

Objective:To observe the clinical effect of No.1 Yinxie Formula treating psoriasis vulgaris.Methods:We randomly divided 102 patients with psoriasis vulgaris into three groups:No.1 Yinxie group(group A),multiglucosid group(group B)and No.1 Yinxie with Glucosidorum Tripterygll Totorum group(group C).The clinical effects were evaluated after 1 month.Results:The rates of the recovery and total significant efficiency of group A were 28.1% and 65.6%,group B were 22.9% and 65.7%,while group C were 45.7% and 85.7%.There were no statistical significances between group A and B under the square Test(P>0.05)while there were obvious statistical significances compared group C with A and B(P<0.05).No.1 Yinxie and multiglucosid was better than separate use while treating psoriasis vulgaris which was been prompted.Conclusion:No.1 Yinxie and multiglucosid has significant effect while treating psoriasis vulgaris which makes it worthy of popularizing in the clinic.